{
  "schemaVersion": 2,
  "eyebrow": "Psychiatry",
  "title": "Suicide Risk Assessment",
  "summary": "Suicide assessment is a repeated, collaborative clinical process that identifies current ideation, intent, planning, access to lethal means, prior behavior, drivers, and protective factors to determine immediate safety actions, treatment needs, and follow-up rather than to assign a static risk category.",
  "seoDescription": "Evidence-grounded approach to suicide risk assessment, safety planning, lethal-means counseling, disposition, and longitudinal management for clinicians.",
  "clinicalQuestion": "How should clinicians assess acute and longitudinal suicide risk and translate findings into safe disposition and management?",
  "specialty": "Psychiatry",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "suicide risk assessment",
    "suicidal ideation",
    "suicide prevention",
    "safety planning",
    "lethal means counseling",
    "self-harm",
    "emergency psychiatry"
  ],
  "keyTakeaways": [
    "Ask directly about suicidal ideation and intent; assess past self-harm, its frequency and medical seriousness, and use of violent methods. [24]",
    "Do not use a screening score, prediction model, or global low-medium-high label as the sole basis for treatment, discharge, or prediction of future suicide or recurrent self-harm. [23]",
    "A positive screen requires a clinically meaningful assessment of ideation, intent, plan, access to lethal means, prior suicidal behavior, acute precipitants, and available supports. [5][20]",
    "Risk assessment is longitudinal: document the formulation and reassess when clinical state, setting, treatment, or access to lethal means changes. [5][9]",
    "When prescribing for a patient who has self-harmed or may self-harm, account for overdose toxicity and access to medicines, including opioid-containing analgesics and tricyclic antidepressants. [23]"
  ],
  "sections": [
    {
      "id": "clinical-principles",
      "eyebrow": "Core approach",
      "heading": "Treat suicide risk assessment as formulation and management, not prediction",
      "intro": "The actionable question is what must change now to reduce imminent danger and sustain follow-up.",
      "paragraphs": [
        "Suicide is a behavior rather than a diagnosis, and suicidal thoughts may occur with or without a mental illness. Individual suicide cannot be predicted accurately at a single time point; assessment therefore should drive a collaborative safety and treatment plan rather than a claim of certainty. [5]",
        "Screening tools can identify patients requiring further assessment, but their classification performance depends on the selected threshold and no universal threshold is appropriate across clinical settings. Clinical context determines the relative consequences of false-positive and false-negative decisions. [1]",
        "Document the patient’s current presentation, longitudinal vulnerabilities, dynamic drivers, mitigating factors, clinical judgment, and specific actions taken. Repeat assessment during the clinical course rather than relying on a baseline designation. [9]"
      ],
      "bullets": [
        "Avoid premature reassurance based on denial of current intent alone; integrate current ideation with behavior history, planning, means access, acute stressors, and ability to engage in a safety plan. [5][20]",
        "Avoid using a global category such as “low risk” as a disposition decision. NICE specifically recommends against global low-medium-high stratification to predict suicide or recurrent self-harm or to determine treatment and discharge. [23]",
        "Use validated screening and structured assessment to improve consistency, but retain individualized clinical formulation and responsibility for disposition. The 2024 VA/DoD guideline recognizes validated screening as part of routine care while noting that outcome effects of prediction models remain uncertain. [6]"
      ],
      "subsections": [],
      "table": {
        "caption": "Assessment domains that should inform an individualized suicide risk formulation rather than a score-based disposition decision. [5][20][23]",
        "columns": [
          "Domain",
          "What to establish",
          "Clinical consequence"
        ],
        "rows": [
          [
            "Current suicidality",
            "Presence, frequency, and trajectory of suicidal thoughts; intent; plan; and preparatory behavior. [5][20]",
            "Determines urgency of containment, psychiatric evaluation, and capacity for outpatient safety planning. [5][20]"
          ],
          [
            "Lethal means",
            "Access to the method contemplated and ability to reduce or transfer access. [5]",
            "Means access is an immediate modifiable target in the safety plan and disposition decision. [5]"
          ],
          [
            "Prior behavior",
            "Past suicide attempts and self-harm, including frequency, medical seriousness, and violent methods. [24]",
            "Past behavior materially informs baseline vulnerability and the needed intensity of monitoring and follow-up. [24]"
          ],
          [
            "Acute drivers and supports",
            "Mental illness, life crisis, substance use, interpersonal circumstances, ambivalence, and available supports. [5]",
            "Identifies treatable precipitants, required collateral involvement, and whether a credible outpatient plan is feasible. [5]"
          ],
          [
            "Engagement and follow-through",
            "Ability to participate in assessment, accept help, adhere to the immediate plan, and access timely care. [5][9]",
            "Determines whether outpatient management can be made sufficiently safe or whether a more protected setting is needed. [5][9]"
          ]
        ]
      }
    },
    {
      "id": "screening-and-assessment",
      "eyebrow": "Detection",
      "heading": "Screen broadly when indicated, then perform a focused clinical assessment",
      "intro": "A screen identifies the need for assessment; it does not establish disposition.",
      "paragraphs": [
        "General medical settings are important detection sites. A cited systematic review found that, on average, 80% of people who died by suicide had primary care contact within the preceding year and 44% within the preceding month, compared with 31% who had mental health care contact in the preceding year. [10]",
        "For adolescents, the American Academy of Pediatrics recommends universal screening from age 12 years during preventive health care and screening at ages 8 to 11 years when clinically indicated. [10] In the ASQ assessment framework, follow-up evaluation includes suicidal-thought frequency, presence of a suicide plan, and past suicidal behavior. [20]",
        "Ask directly about suicidal ideation and intent. In patients with self-harm, establish the history and frequency of prior self-harm, medical seriousness, and use of violent methods. [24] Obtain collateral information when needed for immediate safety and permitted by applicable privacy and emergency exceptions."
      ],
      "bullets": [
        "Clarify whether the patient is describing passive death wishes, active suicidal ideation, intent to act, a specific plan, preparatory behavior, or a recent attempt; these are clinically distinct phenomena. [5][20]",
        "Ask about access to the planned or likely method, including medications, firearms, and other lethal means. [5]",
        "Assess co-occurring mental illness and life crisis without assuming either is required for suicide risk. [5]",
        "Evaluate acute intoxication, delirium, psychosis, severe agitation, or impaired capacity as factors that can limit reliability of interview and ability to engage in an outpatient plan; the supplied sources do not provide validated numeric thresholds for disposition."
      ],
      "subsections": [
        {
          "heading": "Use tools as adjuncts, not gatekeepers",
          "paragraphs": [
            "Risk tools and prediction models may support standardized detection and structured questioning, but evidence does not support using them alone to predict an individual’s future suicide or repeat self-harm. [1][6][23]"
          ],
          "bullets": [
            "Do not use a score or scale to decide who receives treatment or who may be discharged. [23]",
            "Do not convert a dynamic formulation into a fixed global risk label. [23]",
            "If a model is used, document the clinical context and the management action it triggers; threshold choice reflects the harms and benefits of misclassification. [1]"
          ]
        }
      ],
      "table": {
        "caption": "Role of structured approaches in suicide care. [1][6][23]",
        "columns": [
          "Approach",
          "Appropriate use",
          "Inappropriate use"
        ],
        "rows": [
          [
            "Validated screening instrument",
            "Routine detection and identification of patients needing a more complete assessment. [6]",
            "Treating a negative or positive result as a complete individualized risk formulation. [6]"
          ],
          [
            "Structured clinical assessment",
            "Eliciting ideation, plan, intent, prior behavior, means access, drivers, and protective factors. [5][20]",
            "Replacing clinical judgment about current safety, capacity, supports, and disposition. [5]"
          ],
          [
            "Prediction model or score",
            "Potential decision support when paired with a defined clinical pathway and context-specific threshold. [1]",
            "Solely predicting suicide, withholding treatment, or authorizing discharge. [23]"
          ]
        ]
      }
    },
    {
      "id": "acute-management-and-disposition",
      "eyebrow": "Immediate safety",
      "heading": "Match disposition to current danger, modifiable access, and ability to execute a safe plan",
      "intro": "Management begins during assessment and should address both physical and psychiatric needs concurrently.",
      "paragraphs": [
        "For a patient with current suicidal intent, a feasible plan, access to lethal means, recent serious suicidal behavior, or inability to participate reliably in safety planning, prioritize immediate protection, urgent psychiatric evaluation, and a setting capable of continuous observation and escalation. This is a clinical synthesis of the assessment domains emphasized in the cited sources; the supplied results do not provide a validated single threshold for hospitalization. [5][20][24]",
        "In self-harm presentations, physical and mental health care should proceed concurrently whenever possible so that one need does not delay the other. Clear care pathways and communication between teams support safeguarding and de-escalation in emergency settings. [22]",
        "For patients managed outside a protected setting, document why outpatient care is feasible, the patient’s and supports’ roles, immediate steps to reduce lethal-means access, the crisis response plan, and concrete follow-up arrangements. Assessment and management are ongoing processes, including during transitions of care. [5][9]"
      ],
      "bullets": [
        "Do not discharge on the basis of a favorable score, a global “low-risk” designation, or completion of a checklist. [23]",
        "Address access to lethal means explicitly as part of the immediate management plan. [5]",
        "Engage family members or carers and share information as appropriate; support and information for patients and carers are recommended in self-harm care. [23]",
        "Communicate a specific return pathway for worsening suicidal thoughts, intent, inability to follow the plan, or renewed means access; the supplied evidence does not specify a universal follow-up interval."
      ],
      "subsections": [
        {
          "heading": "Medication safety in patients at risk of self-harm",
          "paragraphs": [
            "No medication regimen, dose, or rapid anti-suicidal pharmacotherapy protocol is supported by the supplied search results. Prescribing should nonetheless incorporate overdose risk and medication access. [23]"
          ],
          "bullets": [
            "Consider toxicity in overdose, specifically including opioid-containing analgesics and tricyclic antidepressants. [23]",
            "Review recreational drug and alcohol use when prescribing to a person who has previously self-harmed or may self-harm. [23]",
            "Medication decisions should be integrated with treatment of the underlying psychiatric, substance-use, medical, and psychosocial drivers; agent selection and dosing require current condition-specific guidance not supplied here. [5]"
          ]
        }
      ],
      "table": {
        "caption": "Disposition-focused documentation elements. [5][9][20][24]",
        "columns": [
          "Element",
          "Document explicitly"
        ],
        "rows": [
          [
            "Current suicidal state",
            "Ideation, intent, plan, preparatory behavior, and whether suicidal thoughts are escalating, persistent, or resolving. [5][20]"
          ],
          [
            "Behavioral history",
            "Prior attempts or self-harm; frequency; medical seriousness; and violent methods used. [24]"
          ],
          [
            "Means and mitigation",
            "Access to lethal means, actions taken to reduce access, and who is responsible for those actions. [5]"
          ],
          [
            "Formulation",
            "Static vulnerabilities, dynamic drivers, protective factors, and the reasoning connecting these findings to disposition. [5][9]"
          ],
          [
            "Plan and continuity",
            "Safety actions, treatment referrals, involvement of supports where appropriate, and reassessment or follow-up plan. [5][9][23]"
          ]
        ]
      }
    },
    {
      "id": "longitudinal-management",
      "eyebrow": "Continuity",
      "heading": "Reassess after transitions and treat the drivers of suicidal crisis",
      "intro": "Risk changes with symptoms, circumstances, treatment exposure, and access to means.",
      "paragraphs": [
        "Suicidal crisis often occurs in the context of mental illness or life crisis, and many patients are ambivalent about dying. Use that ambivalence to build a collaborative plan that identifies alternatives to suicidal action, supports, and actions to take as risk intensifies. [5]",
        "Reassessment is particularly important after a new episode of self-harm, changes in suicidal ideation or intent, changes in social circumstances, medication changes, hospital discharge, or renewed access to lethal means. The need for repeated documentation over the clinical course is supported by risk-formulation literature, although the supplied sources do not establish fixed reassessment intervals. [9]",
        "System-level pathways matter: primary care, emergency, inpatient, and behavioral health teams should define how positive screens are assessed, where urgent evaluation occurs, how safety concerns are communicated, and how patients are retained through transitions. Clear pathways and interteam communication can support crisis de-escalation and safeguarding. [22]"
      ],
      "bullets": [
        "At each reassessment, compare current ideation, intent, plan, means access, recent behavior, stressors, treatment engagement, and supports with the prior formulation. [5][9]",
        "Revise the safety and means-restriction plan whenever the anticipated method, environment, caregivers, or available medications change. [5][23]",
        "Avoid therapeutic nihilism: suicidal thoughts are not synonymous with inevitable suicide, and effective support can help patients recover from crisis. [5]"
      ],
      "subsections": [],
      "table": {
        "caption": "Situations warranting renewed clinical formulation rather than reliance on a prior assessment. [5][9][22]",
        "columns": [
          "Trigger",
          "Why reassessment matters",
          "Priority action"
        ],
        "rows": [
          [
            "New or worsening suicidal ideation",
            "Risk is dynamic and cannot be accurately inferred from a prior single-time-point assessment. [5][9]",
            "Reassess intent, plan, means access, precipitants, supports, and disposition. [5][20]"
          ],
          [
            "Self-harm or suicide attempt",
            "Frequency, medical seriousness, and method are clinically relevant history elements. [24]",
            "Provide concurrent physical and mental health assessment and revise the management pathway. [22][24]"
          ],
          [
            "Care transition or discharge",
            "Clinical risk management requires repeated documentation and continuity through the clinical course. [9]",
            "Communicate formulation, safety actions, and follow-up responsibilities across teams. [9][22]"
          ],
          [
            "Medication or means-access change",
            "Medication toxicity and access to lethal means can alter the practical consequences of suicidal intent. [5][23]",
            "Review access, overdose toxicity, and the means-safety plan. [5][23]"
          ]
        ]
      }
    }
  ],
  "faq": [
    {
      "question": "Should a suicide risk score determine emergency department discharge?",
      "answer": "No. Risk tools and global low-medium-high labels should not be used to predict future suicide or recurrent self-harm, decide who receives treatment, or determine discharge. Use structured findings within an individualized formulation and disposition plan. [23]"
    },
    {
      "question": "What should be assessed after a positive suicide screen?",
      "answer": "Assess suicidal-thought frequency, plan, intent, past suicidal behavior or self-harm, access to lethal means, acute drivers, supports, and ability to participate in a safety plan. [5][20][24]"
    },
    {
      "question": "How should clinicians address medication safety in patients at risk of self-harm?",
      "answer": "Consider overdose toxicity and medication access when prescribing, with particular attention to opioid-containing analgesics and tricyclic antidepressants; review recreational drug and alcohol use. [23]"
    },
    {
      "question": "Can suicide be predicted accurately for an individual patient?",
      "answer": "No. Available sources state that suicide cannot be predicted accurately in an individual at a single point in time. Prediction-model thresholds are context dependent and should not replace clinical assessment and management. [1][5]"
    }
  ],
  "references": [
    {
      "number": 1,
      "title": "Suicide risk assessment tools and prediction models: new evidence, methodological innovations, outdated criticisms | BMJ Mental Health",
      "detail": "mentalhealth.bmj.com",
      "url": "https://mentalhealth.bmj.com/content/27/1/e300990",
      "authors": "mentalhealth.bmj.com",
      "host": "mentalhealth.bmj.com"
    },
    {
      "number": 2,
      "title": "Prediction of Suicide Attempts Using Clinician Assessment ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788456",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 3,
      "title": "Risk Model–Guided Clinical Decision Support for Suicide ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828654",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 4,
      "title": "Assessment of suicide risk in mental health practice",
      "detail": "www.thelancet.com",
      "url": "https://www.thelancet.com/article/S2215-0366(22)00232-2/abstract",
      "authors": "www.thelancet.com",
      "host": "www.thelancet.com"
    },
    {
      "number": 5,
      "title": "Suicide risk mitigation - Symptoms, diagnosis and treatment | BMJ Best Practice US",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/1016",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com"
    },
    {
      "number": 6,
      "title": "Clinical guidelines on self-harm and suicide prevention: taking uncertainty into account in the evidence base | BMJ Mental Health",
      "detail": "mentalhealth.bmj.com",
      "url": "https://mentalhealth.bmj.com/content/29/1/e302420",
      "authors": "mentalhealth.bmj.com",
      "host": "mentalhealth.bmj.com"
    },
    {
      "number": 7,
      "title": "Suicide risk mitigation - Symptoms, diagnosis and treatment | BMJ Best Practice",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-gb/1016",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com"
    },
    {
      "number": 8,
      "title": "Assessment and Management of Patients at Risk for Suicide",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-24-01938?download=true",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org"
    },
    {
      "number": 9,
      "title": "Suicide risk assessment and formulation: An update",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S1876201813001949",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 10,
      "title": "Clinical Pathway for Suicide Risk Screening in Adult Primary Care Settings: Special Recommendations",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S2667296022002695",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 11,
      "title": "Suicide risk assessment and suicide risk management ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2451865423000972",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 12,
      "title": "“Suicide Risk Among Physicians in the USA: A Systematic ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/mhs2.70033",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 13,
      "title": "Evaluating the Prevalence of Suicide Risk Screening ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S1553725025000406",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 14,
      "title": "Suicide Risk Management | Wiley Online Books",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/book/10.1002/9780470750933",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 15,
      "title": "Suicide risk assessment and prevention",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/nursingmanagement/fulltext/2018/11000/suicide_risk_assessment_and_prevention.12.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 16,
      "title": "Suicide assessment and treatment in pediatric primary care ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/jcap.12282",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 17,
      "title": "Suicide Biomarkers to Predict Risk, Classify Diagnostic ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ijnp/article/25/3/197/6448067",
      "authors": "academic.oup.com",
      "host": "academic.oup.com"
    },
    {
      "number": 18,
      "title": "Managing Suicidal Patients in the Emergency Department",
      "detail": "www.annemergmed.com",
      "url": "https://www.annemergmed.com/article/S0196-0644(15)01264-0/fulltext",
      "authors": "www.annemergmed.com",
      "host": "www.annemergmed.com"
    },
    {
      "number": 19,
      "title": "Clinical Protocol",
      "detail": "cdn.clinicaltrials.gov",
      "url": "https://cdn.clinicaltrials.gov/large-docs/52/NCT02199652/Prot_SAP_000.pdf",
      "authors": "cdn.clinicaltrials.gov",
      "host": "cdn.clinicaltrials.gov"
    },
    {
      "number": 20,
      "title": "Suicide and Suicide Risk in Adolescents | Pediatrics",
      "detail": "pediatrics.aappublications.org",
      "url": "https://pediatrics.aappublications.org/pediatrics/article/doi/10.1542/peds.2023-064800/196189/Suicide-and-Suicide-Risk-in-Adolescents",
      "authors": "pediatrics.aappublications.org",
      "host": "pediatrics.aappublications.org"
    },
    {
      "number": 21,
      "title": "Overview | Self-harm: assessment, management and preventing recurrence    | Guidance | NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk"
    },
    {
      "number": 22,
      "title": "Self-harm: assessment, management and preventing ...",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225/evidence/e-assessment-in-nonspecialist-settings-pdf-11196377250",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk"
    },
    {
      "number": 23,
      "title": "Recommendations | Self-harm: assessment, management and preventing recurrence    | Guidance | NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225/chapter/Recommendations",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk"
    },
    {
      "number": 24,
      "title": "Scenario: Acute management of a person at risk of self-harm",
      "detail": "cks.nice.org.uk",
      "url": "https://cks.nice.org.uk/topics/self-harm/management/acute-management-of-a-person-at-risk-of-self-harm",
      "authors": "cks.nice.org.uk",
      "host": "cks.nice.org.uk"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "Suicide risk assessment tools and prediction models: new evidence, methodological innovations, outdated criticisms | BMJ Mental Health",
      "detail": "mentalhealth.bmj.com",
      "url": "https://mentalhealth.bmj.com/content/27/1/e300990",
      "authors": "mentalhealth.bmj.com",
      "host": "mentalhealth.bmj.com",
      "snippet": "Furthermore, comparing an individual’s personalised probability estimate with the proposed threshold could improve decision-making in these situations.4 An important area for future research is how best to communicate probability estimates in clinical practice to support decision-making around suici",
      "score": 0.3991562
    },
    {
      "number": 2,
      "title": "Prediction of Suicide Attempts Using Clinician Assessment ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788456",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "by MK Nock · 2022 · Cited by 149 — This prognostic study assesses methods of identifying patients at high risk of suicide attempts within 1 and 6 months after patients",
      "score": 0.36881536
    },
    {
      "number": 3,
      "title": "Risk Model–Guided Clinical Decision Support for Suicide ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828654",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "by CG Walsh · 2025 · Cited by 16 — Of note, this threshold applied in settings without universal screening, whereas the same threshold in universal screening settings was 3%.",
      "score": 0.3118254
    },
    {
      "number": 4,
      "title": "Assessment of suicide risk in mental health practice",
      "detail": "www.thelancet.com",
      "url": "https://www.thelancet.com/article/S2215-0366(22)00232-2/abstract",
      "authors": "www.thelancet.com",
      "host": "www.thelancet.com",
      "snippet": "by K Hawton · 2022 · Cited by 257 — The model of therapeutic risk assessment, formulation, and management we outline in this article regards all patients with mental health problems as potentially",
      "score": 0.28893057
    },
    {
      "number": 5,
      "title": "Suicide risk mitigation - Symptoms, diagnosis and treatment | BMJ Best Practice US",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/1016",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com",
      "snippet": "open menu\n\nWhen viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.\n\n# Suicide risk mitigation\n\nEpidemiology\n\nEtiology\n\nCase history\n\nApproach\n\nHistory and exam\n\nTests\n\nDifferentia",
      "score": 0.26380843
    },
    {
      "number": 6,
      "title": "Clinical guidelines on self-harm and suicide prevention: taking uncertainty into account in the evidence base | BMJ Mental Health",
      "detail": "mentalhealth.bmj.com",
      "url": "https://mentalhealth.bmj.com/content/29/1/e302420",
      "authors": "mentalhealth.bmj.com",
      "host": "mentalhealth.bmj.com",
      "snippet": "The recommendations of NICE on risk assessment tools are in line with the 2016 Royal Australian and New Zealand College of Psychiatrists clinical practice guideline for the management of deliberate self-harm.2 In the USA, the 2024 Department of Veterans Affairs/Department of Defense (VA/DoD) clinica",
      "score": 0.21524386
    },
    {
      "number": 7,
      "title": "Suicide risk mitigation - Symptoms, diagnosis and treatment | BMJ Best Practice",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-gb/1016",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com",
      "snippet": "open menu\n\n# Suicide risk mitigation\n\nEpidemiology\n\nAetiology\n\nCase history\n\nRecommendations\n\nHistory and exam\n\nInvestigations\n\nDifferentials\n\nScreening\n\nRecommendations\n\nTreatment algorithm\n\nEmerging\n\nPrevention\n\nPatient discussions\n\nMonitoring\n\nPrognosis\n\nGuidelines\n\nReferences\n\nPatient informatio",
      "score": 0.32527456
    },
    {
      "number": 8,
      "title": "Assessment and Management of Patients at Risk for Suicide",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-24-01938?download=true",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org",
      "snippet": "by LA Brenner · 2025 · Cited by 19 — The U.S. updated the 2019 joint clinical practice guideline (CPG) for assessing and managing patients who are at risk for suicide.",
      "score": 0.7099254
    },
    {
      "number": 9,
      "title": "Suicide risk assessment and formulation: An update",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S1876201813001949",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "## Conflict of interest\n\nThere are no sources of financial support or conflict of interest to be declared.\n\n## Acknowledgement\n\nI thank Dr. Aparna Muraleedharan for her help in editing the preliminary version of this manuscript.\n\nRecommended articles\n\n## References (77)\n\n   M. Goldacre _et al._\n### ",
      "score": 0.568632
    },
    {
      "number": 10,
      "title": "Clinical Pathway for Suicide Risk Screening in Adult Primary Care Settings: Special Recommendations",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S2667296022002695",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "### Assessment of suicidal thoughts and behaviors in adults: A systematic review of measure psychometric properties and implications for clinical and research utility [...] 2024, Journal of the Academy of Consultation-Liaison Psychiatry  Show abstract We are in a youth mental health crisis with unpr",
      "score": 0.36922464
    },
    {
      "number": 11,
      "title": "Suicide risk assessment and suicide risk management ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2451865423000972",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Open access\n\n## Abstract\n\n### Introduction\n\nSuicide prevention research is a national priority, and national guidance includes the development of suicide risk management protocols (SRMPs) for the assessment and management of suicidal ideation and behavior in research trials. Few published studies de",
      "score": 0.36412215
    },
    {
      "number": 12,
      "title": "“Suicide Risk Among Physicians in the USA: A Systematic ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/mhs2.70033",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "by M Ahsan · 2025 · Cited by 2 — We aim to focus on the recent trends in physician suicide death rates, risk factors and preventive measures related to physicians in the US. We",
      "score": 0.3408586
    },
    {
      "number": 13,
      "title": "Evaluating the Prevalence of Suicide Risk Screening ...",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S1553725025000406",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "2026, Suicide and Life-Threatening Behavior     \n   ### Challenges and Opportunities in Primary Care-Oriented Population-Based Suicide Risk Screening\n\n2026, Journal of General Internal Medicine     \n   ### Clinical updates: Assessment and management of suicidal ideation in adults\n\n2026, BMJ     \n   ",
      "score": 0.33724773
    },
    {
      "number": 14,
      "title": "Suicide Risk Management | Wiley Online Books",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/book/10.1002/9780470750933",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "Suicide Risk Management: A Manual for Health Professionals provides health professionals with the tools to recognize, assess, and manage the",
      "score": 0.30009955
    },
    {
      "number": 15,
      "title": "Suicide risk assessment and prevention",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/nursingmanagement/fulltext/2018/11000/suicide_risk_assessment_and_prevention.12.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "GENERAL PURPOSE: To review the statistical impact of suicide while also presenting concrete steps that nurse managers and nurses can take to diminish the",
      "score": 0.2663643
    },
    {
      "number": 16,
      "title": "Suicide assessment and treatment in pediatric primary care ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/jcap.12282",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "by SM Sisler · 2020 · Cited by 64 — Practice guidelines for the assessment and treatment of patients with suicidal behaviors. Philadelphia, PA: American Psychiatric Association",
      "score": 0.18510641
    },
    {
      "number": 17,
      "title": "Suicide Biomarkers to Predict Risk, Classify Diagnostic ...",
      "detail": "academic.oup.com",
      "url": "https://academic.oup.com/ijnp/article/25/3/197/6448067",
      "authors": "academic.oup.com",
      "host": "academic.oup.com",
      "snippet": "by JN Johnston · 2022 · Cited by 76 — This review summarizes the last 5 years of research into suicide-associated biomarkers and provides a comprehensive guide for promising and novel biomarkers",
      "score": 0.15194441
    },
    {
      "number": 18,
      "title": "Managing Suicidal Patients in the Emergency Department",
      "detail": "www.annemergmed.com",
      "url": "https://www.annemergmed.com/article/S0196-0644(15)01264-0/fulltext",
      "authors": "www.annemergmed.com",
      "host": "www.annemergmed.com",
      "snippet": "by ME Betz · 2016 · Cited by 156 — The Joint Commission requires suicide screening and assessment for patients with primary emotional or behavioral disorders or presenting",
      "score": 0.37230033
    },
    {
      "number": 19,
      "title": "Clinical Protocol",
      "detail": "cdn.clinicaltrials.gov",
      "url": "https://cdn.clinicaltrials.gov/large-docs/52/NCT02199652/Prot_SAP_000.pdf",
      "authors": "cdn.clinicaltrials.gov",
      "host": "cdn.clinicaltrials.gov",
      "snippet": "/id} Participants must provide their own written, informed consent. Participants will have a mild-moderate level of suicidal ideation defined as a SSI score > 3 but will not have imminent intent to commit suicide consistent with a Columbia-Suicide Severity Rating Scale (C-SSRS) suicidal ideation lev",
      "score": 0.2639258
    },
    {
      "number": 20,
      "title": "Suicide and Suicide Risk in Adolescents | Pediatrics",
      "detail": "pediatrics.aappublications.org",
      "url": "https://pediatrics.aappublications.org/pediatrics/article/doi/10.1542/peds.2023-064800/196189/Suicide-and-Suicide-Risk-in-Adolescents",
      "authors": "pediatrics.aappublications.org",
      "host": "pediatrics.aappublications.org",
      "snippet": "In the ASQ Assess the Patient, categories include (1) frequency of suicidal thoughts, (2) if there is a suicide plan, (3) past suicidal behavior",
      "score": 0.18585886
    },
    {
      "number": 21,
      "title": "Overview | Self-harm: assessment, management and preventing recurrence    | Guidance | NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk",
      "snippet": "All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.\n\nLocal commissioners and providers of healthcare have a responsibility to enable the ",
      "score": 0.5752307
    },
    {
      "number": 22,
      "title": "Self-harm: assessment, management and preventing ...",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225/evidence/e-assessment-in-nonspecialist-settings-pdf-11196377250",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk",
      "snippet": "sections of the guideline. The committee agreed, based on their knowledge and expertise, that physical and mental health care should always be delivered concurrently as much as possible in order to prevent a delay in treatment and ensure the patient’s mental or physical needs are not prioritised at ",
      "score": 0.52173984
    },
    {
      "number": 23,
      "title": "Recommendations | Self-harm: assessment, management and preventing recurrence    | Guidance | NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng225/chapter/Recommendations",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk",
      "snippet": "evidence review G: risk assessment and formulation.\n\n### 1.6 Risk assessment tools and scales\n\n#### 1.6.1\n\nDo not use risk assessment tools and scales to predict future suicide or repetition of self-harm.\n\n#### 1.6.2\n\nDo not use risk assessment tools and scales to determine who should and should not",
      "score": 0.4400126
    },
    {
      "number": 24,
      "title": "Scenario: Acute management of a person at risk of self-harm",
      "detail": "cks.nice.org.uk",
      "url": "https://cks.nice.org.uk/topics/self-harm/management/acute-management-of-a-person-at-risk-of-self-harm",
      "authors": "cks.nice.org.uk",
      "host": "cks.nice.org.uk",
      "snippet": "Always ask people directly about suicidal ideation and intent. Consider the history and frequency of any past self-harm, medical seriousness, use of violent",
      "score": 0.2782033
    }
  ],
  "publishedAt": "2026-08-21T00:25:52.038414+00:00",
  "updatedAt": "2026-08-21T00:25:52.038414+00:00",
  "readingMinutes": 6,
  "slug": "suicide-risk-assessment"
}